| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
6,652 |
5,493 |
$176K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
2,631 |
2,208 |
$83K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
1,148 |
1,002 |
$54K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,631 |
1,313 |
$28K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
1,282 |
1,200 |
$26K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
2,022 |
1,869 |
$20K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,249 |
1,048 |
$13K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
332 |
306 |
$9K |
| 36415 |
Collection of venous blood by venipuncture |
1,439 |
1,267 |
$2K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
12 |
12 |
$859.32 |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
13 |
13 |
$471.88 |
| 80305 |
|
24 |
24 |
$181.59 |
| 81025 |
|
14 |
14 |
$91.46 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
13 |
12 |
$73.16 |
| G0008 |
Administration of influenza virus vaccine |
14 |
13 |
$69.09 |
| 81003 |
|
187 |
164 |
$57.81 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
13 |
13 |
$11.57 |